C12N 2760/20052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2760/20052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 5 US grants and 8 published applications in this corpus.
Search patents in C12N- Granted patents
- 5
- Published applications
- 8
- Assignees
- 3
- Inventors
- 6
- Latest grant
- 25 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 2 |
| 2024 | 2 | 1 |
| 2025 | 1 | 1 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of detection and removal of rhabdoviruses from cell lines25 Nov 2025US 12,479,891 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines25 Jun 2024US 12,018,052 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines11 Jun 2024US 12,006,341 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines29 Mar 2022US 11,286,282 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines10 Dec 2019US 10,501,500 B2Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines30 Jul 2026US 2026/0217770 A1Takeda Vaccines, Inc.
- Methods of detection and removal of rhabdoviruses from cell lines3 Apr 2025US 2025/0109172 A1Takeda Vaccines, Inc.
- Recombinant viral expression vectors and methods of use6 Jun 2024US 2024/0182916 A1North Carolina State University
- Methods of detection and removal of rhabdoviruses from cell lines28 Sep 2023US 2023/0303633 A1Takeda Vaccines, Inc.
- Production of High Titer Recombinant Vesicular Stomatitis Virus in Suspension Cell Culture17 Aug 2023US 2023/0257719 A1Regeneron Pharmaceuticals, Inc.
Most cited
By later US patents
- Methods of detection and removal of rhabdoviruses from cell lines4US 10,501,500 B2Takeda Vaccines, Inc. · 2019
- Methods of detection and removal of rhabdoviruses from cell lines3US 11,286,282 B2Takeda Vaccines, Inc. · 2022
- Methods of detection and removal of rhabdoviruses from cell lines1US 12,006,341 B2Takeda Vaccines, Inc. · 2024
- Methods of detection and removal of rhabdoviruses from cell lines1US 12,018,052 B2Takeda Vaccines, Inc. · 2024